Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serodase for inflammation after third molar surgery
NCT02493179Phase 4Unknown
- Sponsor
- Hayat Pharmaceutical Industries Co. PLC
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Replacement Enzymes
01
Overview
A Phase 4 trial of serrapeptase in post-operative inflammation, trismus, postoperative pain, sponsored by Hayat Pharmaceutical Industries Co. PLC. Status: unknown.
02
Drugs
serrapeptase
03
Conditions
post-operative inflammationtrismuspostoperative pain
Beyond the preview
Go deeper on NCT02493179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02493179.